Adenocarcinomas

Clusterin inhibition offers new hope for treating cervical gastric-type adenocarcinoma

April 8, 2026

Gastric-type adenocarcinoma (GAS) is one of the most aggressive non-human papillomavirus (HPV)-associated cervical adenocarcinomas and remains especially difficult…

HHealth

Rare case of pancreatic Hodgkin lymphoma is often misdiagnosed as pancreatic adenocarcinoma

April 3, 2026

Tumors driven by cancer-driving KRAS mutations are often susceptible to ferroptosis, a type of cell death that can…

HHealth

Combined CDK4/6 and EGFR inhibition improves pancreatic cancer therapy

March 13, 2026

Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS…

SScience

Evolutionary mutation in cGAS enhances naked mole-rat DNA repair

February 27, 2026

Background and objectives DNA polymerase epsilon catalytic subunit A (POLE) gene plays a crucial role in DNA repair…

HHealth

NYU Langone strengthens world-leading GI cancer program with renowned leaders

February 12, 2026

Lung cancer patients who have never smoked make up a significant and growing share of global lung cancer…

Clusterin inhibition offers new hope for treating cervical gastric-type adenocarcinoma

Tumor microenvironment drives resistance to ferroptosis in pancreatic cancer

Combined CDK4/6 and EGFR inhibition improves pancreatic cancer therapy

Genomic landscape and clinicopathologic significance of POLE mutant colorectal carcinoma

Rising lung cancer in never smokers demands urgent research focus